Subcellular and metabolic examination of amyloid-β peptides in Alzheimer disease pathogenesis: Evidence for Aβ25–35
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c
Liu, X., Kim, C. N., Yang, J., Jemmerson, R., & Wang, X. (1996) · Cell · doi:10.1016/s0092-8674(00)80085-9 · Cited by 5,167
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599 · cited 1×
“Likewise, the mechanism by which presenilin (PSEN1, PSEN2) missense mutations alter γ-secretase-mediated cleavage to increase the ratio of Aβ1–42 to Aβ1–40 is an important concern due to the highly pathogenic nature of Aβ1–42 (Scheuner et al., 1996).”
BackgroundAlzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168 · cited 2×
“Now, AD affects approximately 15 million people worldwide, and the number of affected individuals in the U.S. and Europe is expected to triple by the year 2050 (Hebert et al., 2003), underscoring the need for effective treatments or preventive interventions.”
BackgroundHydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074 · cited 1×
“Themolecular mechanism of Aβ-induced cytotoxicity has not been fully explored; however this toxicity does involve formation of oxygen radicals (Behl et al., 1994; Harris et al., 1995; Malyshev et al., 2005), nitric oxide (Malyshev et al., 2005; Sutton et al., 1997), and disruption of calcium…”
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921 · cited 5×
“Although Aβ is targeted as one of the primary causes of AD, Aβ is constitutively secreted by mammalian cells and normally occurs in plasma and cerebrospinal fluid (CSF) (Haass et al., 1992; Shoji et al., 1992).”
BackgroundInfluentialSearching for genetic determinants in the new millennium
Risch, N. J. (2000) · Nature · doi:10.1038/35015718 · Cited by 1,839 · cited 2×
“Heterogeneous mutations interact with each other and with non-genetic factors exerting only small or modest effects with weak genotype–phenotype correlations (Risch, 2000).”
BackgroundDeficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., & Van Leuven, F. (1998) · Nature · doi:10.1038/34910 · Cited by 1,818 · cited 1×
“Early studies on presenilins yielded different conclusions with some finding that presenilin is a co-factor for γ-secretase (De Strooper et al., 1998), and others that presenilin is itself a γ-secretase (Wolfe et al., 1999).”
ResultProduction of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing
Shoji, M., Golde, T. E., Ghiso, J., Cheung, T. T., Estus, S., Shaffer, L. M., Cai, X.-D., McKay, D. M., Tintner, R., Frangione, B., et al. (1992) · Science · doi:10.1126/science.1439760 · Cited by 1,447 · cited 4×
“Although Aβ is targeted as one of the primary causes of AD, Aβ is constitutively secreted by mammalian cells and normally occurs in plasma and cerebrospinal fluid (CSF) (Haass et al., 1992; Shoji et al., 1992).”
BackgroundInfluentialA68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau
Lee, V. M.-Y., Balin, B. J., Otvos, L., & Trojanowski, J. Q. (1991) · Science · doi:10.1126/science.1899488 · Cited by 1,418 · cited 1×
“The first neuropathological case was first described over 100 years ago by the presence of senile plaques and neurofibrillary tangles in the brain (Alzheimer, 1907, Lee et al., 1991).”
BackgroundNeurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417
Amyloid, the presenilins and Alzheimer’s disease
Hardy, J. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01030-2 · Cited by 1,370 · cited 2×
“pathogenesis in early-onset AD has lead to the formulation of the amyloid cascade hypothesis (Hardy, 1997).”
BackgroundManczak, M., Anekonda, T. S., Henson, E., Park, B. S., Quinn, J., & Reddy, P. H. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl066 · Cited by 1,104 · cited 1×
“Hydrogen peroxide levels were significantly increased in brain mitochondria of Tg2576 mice and directly correlated with levels of soluble Aβ, suggesting that soluble Aβ may be responsible for the production of Н2О2 in disease progression in Tg2576 mice (Manczak et al., 2006).”
BackgroundHensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., & Butterfield, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3270 · Cited by 1,086 · cited 2×
“In vitro studies have shown that aging is not required for aggregation (Behl et al., 1992; Pike et al., 1995; Shearman et al., 1994) and, unlike the full-length peptide, it forms fibrils immediately after solution (Hensley et al., 1994).”
BackgroundThe incidence of dementia: A meta-analysis
Jorm, A. F., & Jolley, D. (1998) · Neurology · doi:10.1212/wnl.51.3.728 · Cited by 903
De Felice, F. G., Velasco, P. T., Lambert, M. P., Viola, K., Fernandez, S. J., Ferreira, S. T., & Klein, W. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607483200 · Cited by 882 · cited 1×
“Using hippocampal neuronal cultures, De Felice et al. (2007) found that Aβ25–35 stimulated excessive formation of ROS through a mechanism requiring NMDA receptor activation and NMDA receptor-dependent calcium flux.”
BackgroundDementia and Alzheimer Disease Incidence: A Prospective Cohort Study
Kukull, W. A., Higdon, R., Bowen, J. D., McCormick, W. C., Teri, L., Schellenberg, G. D., van Belle, G., Jolley, L., & Larson, E. B. (2002) · Archives of Neurology · doi:10.1001/archneur.59.11.1737 · Cited by 806 · cited 1×
“Additionally, the incidence of AD rises exponentially with age, from 2.5 per thousand people at 65–69 years to 46.1 at 85–89 years (Jorm and Jolley, 1998) and 56.1 in the older than 90 year age group (Kukull et al., 2002).”
BackgroundInfluentialPike, C. J., Walencewicz‐Wasserman, A. J., Kosmoski, J., Cribbs, D. H., Glabe, C. G., & Cotman, C. W. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64010253.x · Cited by 699
Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease
Marcus, D. L., Thomas, C., Rodriguez, C., Simberkoff, K., Tsai, J. S., Strafaci, J. A., & Freedman, M. L. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6750 · Cited by 513 · cited 2×
“antioxidant enzymes SOD, catalase, and glutathione peroxidase (Bogdanovic et al., 2001; Marcus et al., 1998; Schuessel et al., 2004).”
BackgroundCataldo, A. M., Barnett, J. L., Pieroni, C., & Nixon, R. A. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-16-06142.1997 · Cited by 393 · cited 2×
“…al., 2006; Pompl et al., 2003; Zhao et al., 2003), calpain activation (Liu et al., 2005a,b), cathepsin B and D overexpression (Callahan et al., 1999; Cataldo et al., 1997), NOsynthase overexpression (Seyidova et al., 2004), and changes of activities of antioxidant enzymes SOD, catalase, and…”
BackgroundRapid Communication: Characterization of β‐Amyloid Peptide from Human Cerebrospinal Fluid
Vigo‐Pelfrey, C., Lee, D., Keim, P., Lieberburg, I., & Schenk, D. B. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb09841.x · Cited by 385
Clark, C. M., Xie, S., Chittams, J., Ewbank, D., Peskind, E., Galasko, D., Morris, J. C., McKeel, D. W., Farlow, M., Weitlauf, S. L., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1696 · Cited by 357
Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease–like pathology
Schilling, S., Zeitschel, U., Hoffmann, T., Heiser, U., Francke, M., Kehlen, A., Holzer, M., Hutter-Paier, B., Prokesch, M., Windisch, M., et al. (2008) · Nature Medicine · doi:10.1038/nm.1872 · Cited by 357
Zou, K., Gong, J.-S., Yanagisawa, K., & Michikawa, M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-12-04833.2002 · Cited by 305 · cited 1×
“Results obtained by Zou et al. (2002) provided a novel concept that the aggregation-dependent biological effects of Aβ1–40 and Aβ1–42 are dualistic, being either an oxygen radical generator or its inhibitor.”
BackgroundWolfe, M. S., Xia, W., Moore, C. L., Leatherwood, D. D., Ostaszewski, B., Rahmati, T., Donkor, I. O., & Selkoe, D. J. (1999) · Biochemistry · doi:10.1021/bi982562p · Cited by 289 · cited 3×
“, 1998), and others that presenilin is itself a γ-secretase (Wolfe et al., 1999).”
BackgroundResultIntracellular Aβ42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease
Ohyagi, Y., Asahara, H., Chui, D.-H., Tsuruta, Y., Sakae, N., Miyoshi, K., Yamada, T., Kikuchi, H., Taniwaki, T., Murai, H., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2637fje · Cited by 281
Ling, Y., Morgan, K., & Kalsheker, N. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(03)00133-x · Cited by 224 · cited 3×
“…byα-secretase or β-secretase leads to generation and extracellular release of soluble APP fragments, APPs-α and APPs-β, respectively, and the retention of corresponding membrane-linked Cterminal fragments (CTF), C83 and C99 of 83 and 99 amino acid residues, respectively (Ling et al., 2003).”
BackgroundInfluentialSystemic Catabolism of Alzheimer's Aβ40 and Aβ42
Ghiso, J., Shayo, M., Calero, M., Ng, D., Tomidokoro, Y., Gandy, S., Rostagno, A., & Frangione, B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407668200 · Cited by 209 · cited 3×
“Mass spectrometry analysis of the Aβ species in bile following single intravenous injection of mice with Aβ1–40 or Aβ1–42 identified a number of fragments in the bile; however, Aβ25–35 was not found in a variety of tissues (Ghiso et al., 2004).”
BackgroundPortelius, E., Westman-Brinkmalm, A., Zetterberg, H., & Blennow, K. (2006) · Journal of Proteome Research · doi:10.1021/pr050475v · Cited by 206 · cited 3×
“exclude infectious disorders of the central nervous system (CNS) using immunoprecipitation (Portelius et al., 2006).”
BackgroundKuo, Y.-M., Kokjohn, T. A., Watson, M. D., Woods, A. S., Cotter, R. J., Sue, L. I., Kalback, W. M., Emmerling, M. R., Beach, T. G., & Roher, A. E. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64947-4 · Cited by 167 · cited 1×
“Postmortem levels of Aβ1–40 and Aβ1–42 were 208.6 and 783.6 ng/g tissue in the brains of control subjects; Aβ1–40 and Aβ1–42 were 608.2 and 6095.8 ng/g in the brain of AD patients, respectively (Kuo et al., 2000).”
BackgroundInfluentialPereira, C., Santos, M. S., & Oliveira, C. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0241 · Cited by 156 · cited 4×
“Aβ25–35 and Aβ1–40 induced an accumulation of ROS in neuronal hippocampal cultures (Liu and Zhao, 2004, Zeng et al., 2004), rat cortical neurons (Cafe et al., 1996), rat pheochromocytoma line PC12 (Pereira et al., 1999), and rat hippocampus in vivo (Shen et al., 2002).”
BackgroundInfluentialMitochondrial Aβ A potential cause of metabolic dysfunction in Alzheimer's disease
Chen, X., & Yan, S. D. (2006) · IUBMB Life · doi:10.1080/15216540601047767 · Cited by 96 · cited 1×
“…accumulating evidence for impairment of energy metabolism in AD and corresponding injuries in Aβ neurotoxicity (Aliev et al., 2004; Aliyev et al., 2005; Casley et al., 2002; Chen et al., 2006; Chen and Yan, 2006; Moreira et al., 2006; Zhu et al., 2006; Zhu et al., 2004) (“Respiratory chain” in Fig.”
BackgroundGlutamateNMDA receptor NR1 subunit mRNA expression in Alzheimer's disease
Hynd, M. R., Scott, H. L., & Dodd, P. R. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00409.x · Cited by 66 · cited 1×
“…p53 overexpression (Ohyagi et al., 2005), ammonia accumulation (Seiler, 1993; Seiler, 2002), overactivation of NMDA receptors (Dracheva et al., 2001; Hynd et al., 2001), caspase 3 and caspase 9 activation (Matsui et al., 2006; Pompl et al., 2003; Zhao et al., 2003), calpain activation (Liu et al.,…”
BackgroundProtective effect of ecdysterone on PC12 cells cytotoxicity induced by Beta-amyloid25–35
Su-fen, Y., Zhong-jun, W., Zheng-qin, Y., Qin, W., Qi-hai, G., Qi-xin, Z., & Jing-shan, S. (2005) · Chinese Journal of Integrative Medicine · doi:10.1007/bf02835792 · Cited by 10 · cited 2×
“catalase, and glutathione peroxidase (Wang et al., 2005; Yang et al., 2005), and injection of Aβ25–35 into rat hippocampus caused decrease in SOD and glutathione peroxidase activities in brain tissue (Shen et al.”
Background
Cited by
Genetics of β-Amyloid Precursor Protein in Alzheimer's Disease
TCW, J., & Goate, A. M. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024539 · Cited by 242
Armato, U., Chiarini, A., Chakravarthy, B., Chioffi, F., Pacchiana, R., Colarusso, E., Whitfield, J. F., & Dal Prà, I. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.04.020 · Cited by 68
Calcium-Sensing Receptors of Human Neural Cells Play Crucial Roles in Alzheimer's Disease
Chiarini, A., Armato, U., Liu, D., & Dal Prà, I. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00134 · Cited by 51
An isoform‐specific role of FynT tyrosine kinase in Alzheimer's disease
Lee, C., Low, C. Y. B., Francis, P. T., Attems, J., Wong, P. T. ‐., Lai, M. K. P., & Tan, M. G. K. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13429 · Cited by 27
Itokazu, Y., & Yu, R. K. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8634-8 · Cited by 27
Metadata
- Authors
- Kaminsky, Y. G., Marlatt, M. W., Smith, M. A., & Kosenko, E. A.
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 2010-01
- Volume
- 221
- Issue
- 1
- Pages
- 26-37
- ISSN
- 0014-4886 (ISSN-L)
- OpenAlex
- W2093395322
- Cited by
- 165
- References
- 34
- FWCI
- 4.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.